Stifel analyst Mark Astrachan lowered the firm’s price target on Procter & Gamble (PG) to $161 from $167 and keeps a Hold rating on the shares. The firm updated and reduced EPS estimates for P&G and Colgate-Palmolive (CL) ahead of December quarter reporting, mainly reflecting recent negative foreign exchange movement, the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $155 from $163 at Barclays
- Procter & Gamble price target lowered to $189 from $196 at UBS
- Procter & Gamble price target lowered to $181 from $186 at JPMorgan
- Procter & Gamble Restructures to Enhance Global Efficiency
- After a Disappointing Year, Adobe Could Be Due for a Recovery